Amylin To Resubmit Symlin In June; Ex-Guidant Exec Graham Named CEO
Amylin's resubmission plans for Symlin will give the diabetes agent a chance for approval before the end of 2003
Amylin's resubmission plans for Symlin will give the diabetes agent a chance for approval before the end of 2003